SEC Form 4 · accession 0001683168-18-000069
Dougherty's Pharmacy, Inc. · MYDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark S Heil
Officer — President and CFO · Director
Period of report
Dec 27, 2017
Accepted (ET)
Jan 8, 2018 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080029
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2018 | M | 98,532 | — | A | 293,973 | D | |
| Common StockF2 | Jan 1, 2018 | J | 3,909 | — | A | 297,882 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4,F5 | — | Jan 1, 2018 | M | 98,532 | D | — | — | Common Stock | 98,532 | 417,190 | D |
| Restricted Stock UnitsF3,F5 | — | Dec 27, 2017 | J | 8,238 | A | — | — | Common Stock | 8,238 | 425,428 | D |
Explanation of responses
- F1Acquired pursuant to automatic vesting of Restricted Stock Units issued under the Issuer's Restricted Share Unit Incentive Plan.
- F2Acquired pursuant to the Issuer's declaration of a common stock dividend effective as of December 27, 2017.
- F3Issued under the Issuer's Restricted Share Unit Incentive Plan.
- F4Converted pursuant to automatic vesting of Restricted Stock Units issued under the Issuer's Restricted Share Unit Incentive Plan.
- F5Restricted Stock Units vest periodically through January 1, 2022.